Randomized Controlled Trial of Treatment of Male Partners of Women With BV

PHASE3CompletedINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Recurrent Bacterial Vaginosis
Interventions
DRUG

Metronidazole (male partner)

500 mg PO BID for 7 days

OTHER

Placeob (male partner)

matching placebo capsules PO BID for 7 days

Trial Locations (1)

35128

Jane Schwebke, Pell City

All Listed Sponsors
collaborator

Wayne State University

OTHER

lead

University of Alabama at Birmingham

OTHER

NCT02209519 - Randomized Controlled Trial of Treatment of Male Partners of Women With BV | Biotech Hunter | Biotech Hunter